Immage Biotherapeutics Corp: A Snapshot of Current Financials

Immage Biotherapeutics Corp, a biotechnology company based in the United States, is listed on the OTC Bulletin Board. As of May 21, 2025, the company’s close price stood at $0.0001. This figure also represents the 52-week high, indicating a period of stability at this price point. However, the 52-week low for the company was significantly lower at $0.000001, highlighting a period of volatility in the company’s stock performance.

The market capitalization of Immage Biotherapeutics Corp is currently valued at $150 USD. This relatively low market cap reflects the company’s position as a smaller player in the biotechnology sector. Additionally, the price-to-earnings (P/E) ratio is reported as -0.000082, suggesting that the company is not currently generating profits.

Immage Biotherapeutics Corp continues to operate within the competitive landscape of the biotechnology industry, focusing on innovative solutions and advancements. Despite the challenges reflected in its financial metrics, the company remains listed on the OTC Bulletin Board, providing it with a platform to engage with investors and stakeholders.

As the biotechnology sector evolves, Immage Biotherapeutics Corp will likely continue to navigate the complexities of research and development, aiming to achieve breakthroughs that could enhance its financial standing and market presence.